Great meeting with the team at OncoLens to discuss potential collaboration with the WIN Consortium

Inspiring evening at a celebration of ASCO Conquer Cancer, the ASCO Foundation 25th anniversary with half a billion dollars raised since 1999. #ASCO24

Some of my quick mid-conference takes on the insane volume of lung cancer data generated during an eventful #ASCO24! [THREAD]

How do we bring interventions like this to the general Multidisciplinary Cancer Care team. Visit the OncoLens team booth 25149 #ASCO24

#ASCO24 #LAURA I’m putting this 👏standing ovation video out here for all the patients and investigators who participated in this practice changing study. ➡️ But, let’s all remember that we can’t celebrate until all patients get #biomarkertesting and access to these life-saving

.Markey Cancer Center Thoracic Surgeon, Timothy Mullett, MD, presents on results from the smoking cessation, Beyond ASK CoC initiative at #ACSO24 @ACSO UK Research Tim Mullett American College of Surgeons meetings.asco.org/abstracts-pres…

.Markey Cancer Center Medical oncologist Ralph Zinner, MD presents on a clinical trial targeting stage IIIA-C non-small cell #lungcancer (NSCLC) at #ACSO24 @ACSO UK Research meetings.asco.org/abstracts-pres…

.Tim Mullett presents data on CoC BeyondASK, JustASK smoking cessation projects on patient support and treatment strategies, impacting over 1 million patients nationwide. ASCO #ASCO24 American College of Surgeons UK Research Markey Cancer Center UK Dept of Surgery

There is still time to register for the final session of the Project ECHO tele-mentoring series on bispecific antibodies and care coordination. Earn 1.0 CME, CPE, or CNE credit when you complete the session. Register now at bit.ly/3wno9cx. Powered by OncoLens

New Study on the Benefits of Cancer Survivorship Care Tim Mullett, thoracic surgeon at Markey Cancer Center and chair of the ACS Cancer Programs (#ACS) Commission on Cancer (#CoC), co-authored a groundbreaking study on the value of cancer survivorship care standards. This research

It's critical to wait for biomarker results before starting treatment for lung cancer - how do we balance that with the urgency to start treatment quickly? Advice from patient advocate Aurora Lucas & Drs. Mark Kris & Ilit Turgeman in this IASLC podcast. iaslc.org/iaslc-news/lun…

We are excited to announce OncoLens' recognition by Inc. 5000 as one of the Fastest-Growing Private Companies in America, for the second year in a row! inc.com/inc5000/2024

Join us at the ACCC Annual NOC Conference Stop by Booth 623 and learn how The OncoLens Research Network offers relevant, highly curated industry-sponsored initiatives, like clinical trials and disease-specific QIP’s, including innovative programs targeted to improve

Congratulations to #VA2018 & #VA2019 alumni company OncoLens on securing $16M in Series B funding! 🎉 prweb.com/releases/oncol…

It's Friday ‘Fund’ Day! We have funding news from GA-based oncology health tech startup OncoLens, North Carolina-based audio tech company, BrainTap Technologies, and more: buff.ly/4e1eqch

Looking forward to discussing the latest data on Functional Precision Medicine Assays for high grade glioma. Tune in February 12 at noon EST. Kiyatec OncoLens Register below: oncolens.zoom.us/webinar/regist…